Latest Researches in Lung Cancer: Lung Cancer Awareness Month

November Lung Cancer Awareness MonthNovember is celebrated as Lung Cancer Awareness Month all over the world. The purpose is to raise awareness about this disease and help people to successfully survive. The treatment options available for lung cancer patients are improving at a rapid pace. In past few years, various researches and studies have been conducted to come at some significant results. We are dedicated to offering you the latest and helpful information in the arena of lung cancer.

Grape RedGrape Constituent to Cure Lung Cancer

A research has been conducted by a team of scientists from the University of Geneva, Switzerland. They studied a well-known natural product called resveratrol which comes with chemo-preventive properties against cancers. Read in detail here.

Lung Cancer in WomenWomen Experience Early Menopause due to Chemotherapy

Chemotherapy is a significant part of lung cancer treatment. According to the study published in journal Menopause, chemotherapy may cause acute amenorrhea and lead to early menopause among women. The results of the study suggested that chemotherapy for lung cancer patients increases the risk of early loss of menses. Read in detail here.

Artificial Intelligence to Determine Type of Lung Cancer

The researchers at NYU School of Medicine published in Nature Medicine that a type of artificial intelligence could distinguish between two lung cancer types: adenocarcinoma and squamous cell carcinoma. The study provided strong evidence that AI approach can instantly determine the cancer subtype and mutational profile so that patients get started on targeted therapies sooner. Read in detail here.

New Targeted Lung Cancer Treatment

The latest researches in the field of lung cancer also include a new way to tackle the disease. According to the research published in Nature Communications, the scientists have found lung squamous cell carcinoma (LUSC) cells contained high amounts of BCL11A. They showed that manipulating the gene responsible for the protein stopped the development of LUSC. They also found a potential druggable target called SETD8. Read in detail here.

A lot more is required to be done to improve the survival rate among lung cancer patients.

Share your views with us in the comments. 

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.